{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T19:38:19Z","timestamp":1780342699016,"version":"3.54.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100010710","name":"Savitribai Phule Pune University","doi-asserted-by":"crossref","award":["OSD\/BCUD\/230\/9"],"award-info":[{"award-number":["OSD\/BCUD\/230\/9"]}],"id":[{"id":"10.13039\/501100010710","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.ejps.2016.01.009","type":"journal-article","created":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T21:47:28Z","timestamp":1452289648000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Fabrication and efficacy evaluation of chloroquine nanoparticles in CFA-induced arthritic rats using TNF-\u03b1 ELISA"],"prefix":"10.1016","volume":"84","author":[{"given":"Mangesh R.","family":"Bhalekar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant G.","family":"Upadhaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwini R.","family":"Madgulkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejps.2016.01.009_bb0005","first-page":"1","article-title":"Determination of physicochemical properties of pyronaridine: a new antimalarial drug","volume":"19","author":"Adegoke","year":"2006","journal-title":"Pak. J. Pharm. Sci."},{"issue":"13","key":"10.1016\/j.ejps.2016.01.009_bb0010","first-page":"1","article-title":"Demonstration of a novel technique to quantitatively assess inflammatory mediators and cells in rat knee joints","volume":"4","author":"Barton","year":"2007","journal-title":"J. Inflamm."},{"issue":"2","key":"10.1016\/j.ejps.2016.01.009_bb0015","first-page":"125","article-title":"Quantitative determination of chloroquine and desethylchloroquine in biological fluids by high performance thin layer chromatography","volume":"43","author":"Betschart","year":"1986","journal-title":"Acta Trop."},{"issue":"1","key":"10.1016\/j.ejps.2016.01.009_bb0020","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1208\/s12249-009-9199-0","article-title":"Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery","volume":"10","author":"Bhalekar","year":"2009","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2016.01.009_bb0025","series-title":"In-vivo Bioavailability and Lymphatic Uptake Evaluation of Lipid Nanoparticulates of Darunavir","author":"Bhalekar","year":"2015"},{"issue":"2","key":"10.1016\/j.ejps.2016.01.009_bb0030","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.injr.2015.03.008","article-title":"Anti-rheumatic activity of chloroquine-SLN gel on Wistar rats using complete Freund's adjuvant (CFA) model","volume":"10","author":"Bhalekar","year":"2015","journal-title":"Indian J. Rheumatol."},{"issue":"1\u20132","key":"10.1016\/j.ejps.2016.01.009_bb0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jconrel.2007.03.022","article-title":"Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers","volume":"121","author":"Champion","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2016.01.009_bb0040","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1472-6882-10-56","article-title":"Evaluation of antiarthritic activity of Strychnos potatorum Linn seeds in Freund's adjuvant induced arthritic rat model","volume":"10","author":"Ekambaram","year":"2010","journal-title":"BMC Complement. Altern. Med."},{"issue":"3","key":"10.1016\/j.ejps.2016.01.009_bb0045","first-page":"275","article-title":"Changes in some pharmacokinetics parameters of chloroquine by Gnetum africana","volume":"5","author":"Eseyin","year":"2012","journal-title":"Maced. J. Med. Sci."},{"key":"10.1016\/j.ejps.2016.01.009_bb0050","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1146\/annurev.immunol.14.1.397","article-title":"Role of cytokines in rheumatoid arthritis","volume":"14","author":"Feldmann","year":"1996","journal-title":"Annu. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.ejps.2016.01.009_bb0055","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/ard.15.3.251","article-title":"Chloroquine and rheumatoid arthritis; a short-term controlled trial","volume":"15","author":"Freedman","year":"1956","journal-title":"Ann. Rheum. Dis."},{"issue":"1\u20132","key":"10.1016\/j.ejps.2016.01.009_bb0060","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijpharm.2011.12.037","article-title":"Loading hydrophilic drug in solid lipid media as nanoparticles: statistical modeling of entrapment efficiency and particle size","volume":"424","author":"Gadhiri","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.ejps.2016.01.009_bb0065","first-page":"23","article-title":"Formulation and optimization of itraconazole polymeric lipid hybrid nanoparticles (Lipomer) using Box\u2013Behnken","volume":"23","author":"Gajre","year":"2015","journal-title":"DARU J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.ejps.2016.01.009_bb0070","first-page":"251","article-title":"Bioavailability assessment of simvastatin loaded solid lipid nanoparticles after oral administration","volume":"6","author":"Gambhire","year":"2011","journal-title":"Asian J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ejps.2016.01.009_bb0075","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.colsurfb.2007.07.015","article-title":"Solid lipid nanoparticles prepared by solvent diffusion method in a nanoreactor system","volume":"61","author":"Huang","year":"2008","journal-title":"Colloids Surf. B"},{"issue":"6","key":"10.1016\/j.ejps.2016.01.009_bb0080","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/rheumatology\/kei282","article-title":"Chloroquine inhibits production of TNF-\u03b1, IL-1\u03b2 and IL-6 from lipopolysaccharide-stimulated human monocytes\/macrophages by different modes","volume":"45","author":"Jang","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.ejps.2016.01.009_bb0085","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejps.2008.07.003","article-title":"Intestinal lymphatic transport of halofantrine in rats assessed using a chylomicron flow blocking approach: the influence of polysorbate 60 and 80","volume":"35","author":"Lind","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2016.01.009_bb0090","first-page":"13","article-title":"Effect of composition in nanostructured lipid carriers (NLC) on skin hydration and occlusion","volume":"8","author":"Loo","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ejps.2016.01.009_bb0095","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.amjmed.2007.04.005","article-title":"Rheumatoid arthritis: diagnosis and management","volume":"120","author":"Majithia","year":"2007","journal-title":"Am. J. Med."},{"issue":"1","key":"10.1016\/j.ejps.2016.01.009_bb0100","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery\u2014a review of the state of the art","volume":"50","author":"M\u00fcller","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2016.01.009_bb0105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.colsurfa.2013.12.023","article-title":"Solid lipid nanoparticles (SLN) stabilized with polyhydroxy surfactants: preparation, characterization and physical stability investigation","volume":"444","author":"Kovacevic","year":"2014","journal-title":"Colloids Surf. A"},{"issue":"4","key":"10.1016\/j.ejps.2016.01.009_bb0110","first-page":"966","article-title":"A study on the effects of different surfactants on ethylcellulose microspheres","volume":"1","author":"Pachuau","year":"2009","journal-title":"Int. J. Pharm. Technol. Res."},{"key":"10.1016\/j.ejps.2016.01.009_bb0115","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1053\/berh.2001.0194","article-title":"Signal transduction in rheumatoid arthritis","volume":"15","author":"Piecyk","year":"2001","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.ejps.2016.01.009_bb0120","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejpb.2013.12.015","article-title":"Lipid nanoparticles for oral delivery of raloxifene: optimization, stability, in vivo evaluation and uptake mechanism","volume":"87","author":"Ravi","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2016.01.009_bb0125","first-page":"1097","article-title":"Lymphatic transport of orally administered drug","volume":"40","author":"Reddy","year":"2002","journal-title":"Indian J. Exp. Biol."},{"issue":"2","key":"10.1016\/j.ejps.2016.01.009_bb0130","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2217\/nnm.09.110","article-title":"Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery","volume":"5","author":"Roger","year":"2010","journal-title":"Nanomedicine"},{"issue":"7","key":"10.1016\/j.ejps.2016.01.009_bb0135","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/rheumatology\/36.7.799","article-title":"Antimalarial drugs in the treatment of rheumatological diseases","volume":"36","author":"Rynes","year":"1997","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.ejps.2016.01.009_bb0140","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jconrel.2010.01.036","article-title":"Endocytosis of nanomedicines","volume":"145","author":"Sahay","year":"2010","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.ejps.2016.01.009_bb0145","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00393-012-1083-8","article-title":"Evaluation of complete Freund's adjuvant-induced arthritis in a Wistar rat model comparison of thermography and histopathology","volume":"72","author":"Snekhalatha","year":"2012","journal-title":"Z. Rheumatol."},{"issue":"3","key":"10.1016\/j.ejps.2016.01.009_bb0150","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1208\/s12249-011-9665-3","article-title":"Preparation, characterization, pharmacokinetics and tissue distribution of solid lipid nanoparticles loaded with tetrandrine","volume":"12","author":"Su","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2016.01.009_bb0155","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S1357-2725(03)00259-0","article-title":"Rheumatoid arthritis: regulation of synovial inflammation","volume":"36","author":"Sweeney","year":"2004","journal-title":"Int. J. Biol. Chem. Cell Biol."},{"key":"10.1016\/j.ejps.2016.01.009_bb0160","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3923\/ijp.2009.181.190","article-title":"Anti-arthritic effects of Palisota hirsuta K. Schum. Leaf extract in Freund's adjuvant-induced arthritis in rats","volume":"5","author":"Woode","year":"2009","journal-title":"Int. J. Pharmacol."},{"key":"10.1016\/j.ejps.2016.01.009_bb0165","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ijpharm.2007.10.014","article-title":"Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis","volume":"352","author":"Ye","year":"2008","journal-title":"Int. J. Pharm."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098716300057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098716300057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T04:56:04Z","timestamp":1589604964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098716300057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":33,"alternative-id":["S0928098716300057"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2016.01.009","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fabrication and efficacy evaluation of chloroquine nanoparticles in CFA-induced arthritic rats using TNF-\u03b1 ELISA","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2016.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}